Home › Funds › Rubric Capital Management LP › AMRX
Rubric Capital Management LP position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Rubric Capital Management LP reported holding 10,168,660 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$176.0M, representing 1.63% of its reported portfolio and ranking #19 among its reported holdings. Rubric Capital Management LP has disclosed AMRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Rubric Capital Management LP's AMRX position evolved
Rubric Capital Management LP first disclosed a stake in AMRX in Q3 2023 at 4,024,500 shares (US$17.0M). The position peaked in Q2 2026 at 10,168,660 shares, worth US$176.0M. Across 12 filings, Rubric Capital Management LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 10,168,660 shares valued at US$176.0M — a reduction of -868,929 shares quarter over quarter.. Notable position changes include a 99% increase in Q4 2023 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.02M | $16.98M | New |
| Q4 2023 | 8.00M | $48.56M | Add |
| Q1 2024 | 9.54M | $57.82M | Add |
| Q2 2024 | 10.72M | $68.08M | Add |
| Q3 2024 | 10.72M | $89.21M | Hold |
| Q4 2024 | 10.72M | $84.92M | Hold |
| Q1 2025 | 10.74M | $89.97M | Hold |
| Q2 2025 | 11.71M | $94.74M | Add |
| Q3 2025 | 12.33M | $123.47M | Add |
| Q4 2025 | 12.33M | $155.42M | Hold |
| Q1 2026 | 11.04M | $137.20M | Reduce |
| Q2 2026 | 10.17M | $176.02M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Nantahala Capital Management, LLC (US$39.3M), Westshore Wealth, LLC (US$23.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $213.41M · Q2 2026
- Nantahala Capital Management, LLC 2.27M sh · $39.27M · Q2 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- BlackBarn Capital Partners LP 1.30M sh · $22.50M · Q2 2026
- Penn Capital Management Company, LLC 1.18M sh · $20.48M · Q2 2026
- TUCKER ASSET MANAGEMENT LLC 1.01M sh · $17.50M · Q2 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Rubric Capital Management LP
FAQ
How long has Rubric Capital Management LP held AMRX?
Rubric Capital Management LP has disclosed AMRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Rubric Capital Management LP's current position in AMRX?
As of Q2 2026, Rubric Capital Management LP holds 10.17M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $176.02M, representing 1.63% of its reported portfolio and ranking #19.
Has Rubric Capital Management LP been buying or selling AMRX?
In the latest 13F filing (Q2 2026), Rubric Capital Management LP reduced its position in AMRX. The position peaked in Q2 2026 at 10.17M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Nantahala Capital Management, LLC, Westshore Wealth, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.